Related references
Note: Only part of the references are listed.Horizontal spread of pericolic lymph node metastasis as a prognostic factor for recurrence in Stage III colorectal cancer
Taketo Sasaki et al.
COLORECTAL DISEASE (2021)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Verification of the Japanese staging system for rectal cancer, focusing on differences with the TNM classification
Michiru Arabiki et al.
SURGERY TODAY (2020)
Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]
Kenjiro Kotake
JOURNAL OF THE ANUS RECTUM AND COLON (2019)
Prominent Information of jN3 Positive in Stage III Colorectal Cancer Removed by D3 Dissection: Retrospective Analysis of 6866 Patients From a Multi-institutional Database in Japan
Eiji Shinto et al.
DISEASES OF THE COLON & RECTUM (2018)
Survival Benefit of Japanese Extended Lymphadenectomy for Clinically Node-Negative and Node-Positive Colorectal Cancers
Akira Ouchi et al.
DISEASES OF THE COLON & RECTUM (2018)
Resection of Colorectal Cancer With Versus Without Preservation of Inferior Mesenteric Artery
Yoshiaki Mihara et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
Masahito Kotaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Prognostic Impact of Distribution of Lymph Node Metastases in Stage III Colon Cancer
Toshiya Nagasaki et al.
WORLD JOURNAL OF SURGERY (2015)
Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205
Yasuhiro Shimada et al.
EUROPEAN JOURNAL OF CANCER (2014)
Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer
Kenjiro Kotake et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Yong Sang Hong et al.
LANCET ONCOLOGY (2014)
D3 Lymph Node Dissection in Right Hemicolectomy with a No-touch Isolation Technique in Patients With Colon Cancer
Yukihide Kanemitsu et al.
DISEASES OF THE COLON & RECTUM (2013)
Distribution of Lymph Node Metastases Is an Independent Predictor of Survival for Sigmoid Colon and Rectal Cancer
Jung Wook Huh et al.
ANNALS OF SURGERY (2012)
Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection
S. D. Lee et al.
EJSO (2012)
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
Daniel G. Haller et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic Review
W. Ceelen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome
W. Hohenberger et al.
COLORECTAL DISEASE (2009)
Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer
H Kobayashi et al.
SURGERY (2006)
Number versus distribution in classifying regional lymph node metastases from colon cancer
J Hida et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer
JC Kim et al.
EJSO (2004)
Share Paper
